Waters (WAT +0.2%) acquires exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. Terms weren’t disclosed.
"The acquisition of DESI technology bolsters Waters' portfolio of mass spectrometry imaging innovations, a rapidly expanding MS technique for biomedical research and related applications," said Chris O'Connell, Chairman and CEO, Waters Corporation.
Now read: Lockheed to add 400 more F-35 jobs »
Subscribe for full text news in your inbox